Literature DB >> 22823436

Autoimmune diseases and infections as risk factors for schizophrenia.

Michael E Benros1, Preben B Mortensen, William W Eaton.   

Abstract

Immunological hypotheses have become increasingly prominent when studying the etiology of schizophrenia. Autoimmune diseases, and especially the number of infections requiring hospitalization, have been identified as significant risk factors for schizophrenia in a dose-response relationship, which seem compatible with an immunological hypothesis for subgroups of patients with schizophrenia. Inflammation and infections may affect the brain through many different pathways that are not necessarily mutually exclusive and can possibly increase the risk of schizophrenia in vulnerable individuals. However, the findings could also be an epiphenomenon and not causal, due to, for instance, common genetic vulnerability, which could be supported by the observations of an increased prevalence of autoimmune diseases and infections in parents of patients with schizophrenia. Nevertheless, autoimmune diseases and infections should be considered in the treatment of individuals with schizophrenia symptoms, and further research is needed of the immune system's possible contributing pathogenic factors in the etiology of schizophrenia.
© 2012 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22823436     DOI: 10.1111/j.1749-6632.2012.06638.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  58 in total

1.  Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective study.

Authors:  Marie Kim Wium-Andersen; David Dynnes Ørsted; Børge Grønne Nordestgaard
Journal:  Schizophr Bull       Date:  2013-08-31       Impact factor: 9.306

2.  Improvement in psychotic symptoms after a gluten-free diet in a boy with complex autoimmune illness.

Authors:  William W Eaton; Lian-Yu Chen; F Curtis Dohan; Deanna L Kelly; Nicola Cascella
Journal:  Am J Psychiatry       Date:  2015-03-01       Impact factor: 18.112

3.  Meta-analysis of Positive and Negative Symptoms Reveals Schizophrenia Modifier Genes.

Authors:  Alexis C Edwards; Tim B Bigdeli; Anna R Docherty; Silviu Bacanu; Donghyung Lee; Teresa R de Candia; Arden Moscati; Dawn L Thiselton; Brion S Maher; Brandon K Wormley; Dermot Walsh; Francis A O'Neill; Kenneth S Kendler; Brien P Riley; Ayman H Fanous
Journal:  Schizophr Bull       Date:  2015-08-27       Impact factor: 9.306

4.  Soluble urokinase-type plasminogen activator receptor levels in patients with schizophrenia.

Authors:  Jimmi Nielsen; Rasmus Røge; Sofie Gry Pristed; Anne Grethe Viuff; Henrik Ullum; Lise Wegner Thørner; Thomas Werge; Torkel Vang
Journal:  Schizophr Bull       Date:  2014-08-25       Impact factor: 9.306

Review 5.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

6.  Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: correlation with psychopathology and cognition.

Authors:  Meng Han Lv; Yun Long Tan; Shao Xiao Yan; Li Tian; Da Chun Chen; Shu Ping Tan; Zhi Ren Wang; Fu De Yang; Jin H Yoon; Giovana B Zunta-Soares; Jair C Soares; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2014-06-24       Impact factor: 4.530

Review 7.  Psychosis: an autoimmune disease?

Authors:  Adam A J Al-Diwani; Thomas A Pollak; Sarosh R Irani; Belinda R Lennox
Journal:  Immunology       Date:  2017-08-03       Impact factor: 7.397

8.  Eating Disorders, Autoimmune, and Autoinflammatory Disease.

Authors:  Stephanie Zerwas; Janne Tidselbak Larsen; Liselotte Petersen; Laura M Thornton; Michela Quaranta; Susanne Vinkel Koch; David Pisetsky; Preben Bo Mortensen; Cynthia M Bulik
Journal:  Pediatrics       Date:  2017-11-09       Impact factor: 7.124

9.  Schizophrenia among patients with systemic lupus erythematosus: population-based cross-sectional study.

Authors:  S Tiosano; A Farhi; A Watad; N Grysman; R Stryjer; H Amital; D Comaneshter; A D Cohen; D Amital
Journal:  Epidemiol Psychiatr Sci       Date:  2016-07-26       Impact factor: 6.892

10.  Activated Phosphorylated STAT1 Levels as a Biologically Relevant Immune Signal in Schizophrenia.

Authors:  Rajiv P Sharma; Cherise Rosen; Jennifer K Melbourne; Benjamin Feiner; Kayla A Chase
Journal:  Neuroimmunomodulation       Date:  2016-11-08       Impact factor: 2.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.